T41	Symptom 2147 2192	DCP loss and the corresponding OPL disruption
T40	Anatomy 2127 2131	eyes
T21	Symptom 1027 1099	reduction of less than 50 μm or an increase in central retinal thickness
T20	Symptom 893 950	reduction of more than 50 μm in central retinal thickness
T23	Diagnostic_tool 1258 1271	SD OCT images
T22	Characteristic 1144 1197	vascular density and foveal avascular zone (FAZ) area
T25	Disease 1320 1332	non-DME eyes
T24	Diagnostic_tool 1291 1295	OCTA
T27	Anatomy 1338 1342	eyes
T26	Disease 1334 1337	DME
T29	Characteristic 1390 1454	larger FAZ area (P  <  0.001) in the DCP and more microaneurysms
T28	Characteristic 1349 1371	lower vascular density
T1	Diagnostic_tool 0 40	Optical Coherence Tomography Angiography
T2	Disease 44 47	DME
T3	Characteristic 123 188	structural integrity of the superficial capillary plexuses (SCPs)
T4	Diagnostic_tool 193 258	deep capillary plexuses (DCPs) using optical coherence tomography
T5	Diagnostic_tool 260 282	OCT) angiography (OCTA
T6	Disease 301 323	diabetic macular edema
T7	Disease 325 328	DME
T8	Disease 479 482	DME
T9	Anatomy 483 487	eyes
T30	Symptom 1617 1671	show greater damage and more microaneurysms in the DCP
T10	Disease 548 551	DME
T32	Characteristic 1727 1826	topographic location of the disrupted synaptic portion of the outer plexiform layer (OPL) in SD OCT
T31	Characteristic 1692 1707	larger FAZ area
T12	Anatomy 623 627	eyes
T34	Disease 1902 1905	DME
T11	Anatomy 552 556	eyes
T33	Characteristic 1855 1886	nonflow area of the DCP in OCTA
T14	Diagnostic_tool 700 704	OCTA
T36	Characteristic 1929 2034	anti-VEGF treatment, poor responders show significant damage to the integrity of the DCP, but not the SCP
T13	Disease 636 639	DME
T35	Anatomy 1906 1910	eyes
T16	Diagnostic_tool 730 736	SD OCT
T38	Symptom 2111 2119	DCP loss
T15	Diagnostic_tool 709 728	spectral-domain OCT
T37	Characteristic 2050 2086	OPL disruption in SD OCT corresponds
T18	Anatomy 813 816	SCP
T17	Diagnostic_tool 794 805	OCTA images
T39	Disease 2123 2126	DME
T19	Anatomy 848 851	eye
